When TAP Pharmaceutical Products Inc.'s national account executive Janice Swirski offered Joseph Gerstein, MD, an administrator with Tufts Health Plan, a $40,000 “unrestricted educational grant” to put TAP's drug Lupron on Tufts' formulary — she picked the wrong doctor for a bribe. For years, Gerstein has written newsletters deriding pharma marketing practices. But TAP had gone too far. Gerstein reported the incident to federal prosecutors, and helped them build a case that resulted in the ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.